New ethnicity diabetes drug criteria make ‘huge’ difference to Māori and Pacific uptake

+Print Archive
News

New ethnicity diabetes drug criteria make ‘huge’ difference to Māori and Pacific uptake

NZD

New Zealand Doctor Rata Aotearoa

Trevor Simpson
Pharmac chief advisor, Māori, Trevor Simpson says it’s time to put an ethical stake in the ground over inequity

Pharmac's First ethnicity criteria for a Special Authority drug have led to a “fantastic” Māori uptake of new diabetes medications, says National Hauora Coalition clinical director and GP Rawiri McKree Jansen.

Just under 28,000 people with highrisk type 2 diabetes were approved for the SLGT2 inhibitor drug Empagliflozin within four and a half months of Pharm